174 filings
8-K
EVOK
Evoke Pharma Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EVOK
Evoke Pharma Inc
21 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
EVOK
Evoke Pharma Inc
18 Mar 24
Other Events
5:02pm
8-K
EVOK
Evoke Pharma Inc
14 Mar 24
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
4:00pm
8-K
EVOK
Evoke Pharma Inc
23 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
xd1wbfbog gkyz
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
8-K
mvsnnwib7hud2
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
8-K
r1by5iqksrjhq pdwf
29 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
j600nx
27 Nov 23
Other Events
4:30pm
8-K
3zxjod
22 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
tc5e 0vztbnt2uzpx
9 Nov 23
Evoke Pharma Reports Third Quarter 2023 Financial Results
9:00am
8-K
2s89olbk8s nfhbekg
1 Nov 23
Other Events
8:30am
8-K
zf12e5yra 4p6bf
12 Oct 23
Entry into a Material Definitive Agreement
4:30pm
8-K
92lwipw5zmwj0p tss55
10 Aug 23
Evoke Pharma Reports Second Quarter 2023 Financial Results
9:03am
8-K
1i5b6l9fa ey
21 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
exub22rbmnew vp
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
rpdd7m2gmw1nj ag66
15 May 23
Evoke Pharma Reports First Quarter 2023 Financial Results
4:23pm
8-K
4zl9121hojgblda jr
11 May 23
Departure of Directors or Certain Officers
4:00pm
8-K
p1di8h40okkytbv5i5
9 May 23
Other Events
10:00am
8-K
31ao9o597l1b
1 May 23
Other Events
4:04pm